Warning: The NCBI web site requires JavaScript to function. more...
A pilot study of IL-1 inhibition by anakinra in acute gout.
So A, De Smedt T, Revaz S, Tschopp J.
Arthritis Res Ther. 2007;9(2):R28.
Related citations
Gout-associated uric acid crystals activate the NALP3 inflammasome.
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J.
Nature. 2006 Mar 9;440(7081):237-41. Epub 2006 Jan 11.
Plasma interleukin (IL)-18 (interferon-gamma-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18.
Inokuchi T, Moriwaki Y, Tsutsui H, Yamamoto A, Takahashi S, Tsutsumi Z, Ka T, Nakanishi K, Yamamoto T.
Cytokine. 2006 Jan 7;33(1):21-7. Epub 2006 Jan 5.
Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.
Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S, Hylton DM, Rudge JS, Liu-Bryan R, Terkeltaub RA, Yancopoulos GD, Murphy AJ.
Ann Rheum Dis. 2009 Oct;68(10):1602-8. Epub 2009 Jun 14.
Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.
Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, van de Veerdonk FL, Stalenhoef AF, Giamarellos-Bourboulis EJ, Kanneganti TD, van der Meer JW.
Arthritis Rheum. 2010 Nov;62(11):3237-48. doi: 10.1002/art.27667.
The inflammasome, autoinflammatory diseases, and gout.
Pétrilli V, Martinon F.
Joint Bone Spine. 2007 Dec;74(6):571-6. Epub 2007 Aug 21. Review.
Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout.
Martin WJ, Walton M, Harper J.
Arthritis Rheum. 2009 Jan;60(1):281-9.
NALP3 inflammasome functional polymorphisms and gout susceptibility.
Miao ZM, Zhao SH, Yan SL, Li CG, Wang YG, Meng DM, Zhou L, Mi QS.
Cell Cycle. 2009 Jan 1;8(1):27-30. Epub 2009 Jan 31.
Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?
Verma D, Lerm M, Blomgran Julinder R, Eriksson P, Söderkvist P, Särndahl E.
Arthritis Rheum. 2008 Mar;58(3):888-94.
Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis.
Tramontini N, Huber C, Liu-Bryan R, Terkeltaub RA, Kilgore KS.
Arthritis Rheum. 2004 Aug;50(8):2633-9.
Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM, Sydlaske AD, Agha-Babakhani A, Johnson K, Terkeltaub R.
Arthritis Rheum. 2006 Oct;54(10):3363-71.
Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.
Tran AP, Edelman J.
Int J Rheum Dis. 2011 Aug;14(3):e33-7. doi: 10.1111/j.1756-185X.2011.01629.x.
[New aspects of the pathogenesis of gout. Danger signals, autoinflammation and beyond].
Lamprecht P, Till A, Kabelitz D.
Z Rheumatol. 2008 Mar;67(2):151-6. Review. German.
Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1beta levels in inflamed and osteosarcoma-bearing mice.
Baamonde A, Curto-Reyes V, Juárez L, Meana A, Hidalgo A, Menéndez L.
Life Sci. 2007 Aug 2;81(8):673-82. Epub 2007 Jul 18.
Difficult-to-treat gouty arthritis: a disease warranting better management.
Schlesinger N.
Drugs. 2011 Jul 30;71(11):1413-39. doi: 10.2165/11592290-000000000-00000. Review.
Is IL-1 a good therapeutic target in the treatment of arthritis?
Burger D, Dayer JM, Palmer G, Gabay C.
Best Pract Res Clin Rheumatol. 2006 Oct;20(5):879-96. Review.
[New knowledge on the pathophysiology and therapy of gout].
So A.
Z Rheumatol. 2007 Nov;66(7):562, 564-7. Review. German.
Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.
McGonagle D, Tan AL, Shankaranarayana S, Madden J, Emery P, McDermott MF.
Ann Rheum Dis. 2007 Dec;66(12):1683-4. No abstract available.
Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.
Nuki G.
Curr Rheumatol Rep. 2008 Jul;10(3):218-27. Review.
Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations.
Leslie KS, Lachmann HJ, Bruning E, McGrath JA, Bybee A, Gallimore JR, Roberts PF, Woo P, Grattan CE, Hawkins PN.
Arch Dermatol. 2006 Dec;142(12):1591-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on